These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11565626)

  • 1. Pharmacokinetics of valproic acid in patients with bipolar disorder.
    Vasudev K; Das S; Goswami U; Tayal G
    J Psychopharmacol; 2001 Sep; 15(3):187-90. PubMed ID: 11565626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of valproate plasma concentrations and dose in bipolar affective disorder.
    Perry PJ; Bever-Stille KA; Arndt S; Gundersen S
    J Clin Psychopharmacol; 2000 Apr; 20(2):277-9. PubMed ID: 10770477
    [No Abstract]   [Full Text] [Related]  

  • 3. Does valproic acid warrant therapeutic drug monitoring in bipolar affective disorder?
    Haymond J; Ensom MH
    Ther Drug Monit; 2010 Feb; 32(1):19-29. PubMed ID: 19901867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous valproate loading in acutely manic and depressed bipolar I patients.
    Grunze H; Erfurth A; Amann B; Giupponi G; Kammerer C; Walden J
    J Clin Psychopharmacol; 1999 Aug; 19(4):303-9. PubMed ID: 10440456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deconstructing a medication regimen.
    Preskorn SH
    J Psychiatr Pract; 2008 Mar; 14(2):114-8. PubMed ID: 18360197
    [No Abstract]   [Full Text] [Related]  

  • 6. Risperidone does not affect steady-state pharmacokinetics of divalproex sodium in patients with bipolar disorder.
    Ravindran A; Silverstone P; Lacroix D; van Schaick E; Vermeulen A; Alexander J
    Clin Pharmacokinet; 2004; 43(11):733-40. PubMed ID: 15301577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate-induced encephalopathy related to concurrent antimanic medications.
    Trojak B; de la Gastine B; Dollfus S
    J Neuropsychiatry Clin Neurosci; 2011; 23(1):E22-3. PubMed ID: 21304120
    [No Abstract]   [Full Text] [Related]  

  • 8. Population Pharmacokinetics of Valproic Acid in Patients with Mania: Implication for Individualized Dosing Regimens.
    Methaneethorn J
    Clin Ther; 2017 Jun; 39(6):1171-1181. PubMed ID: 28483293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open-label steady-state pharmacokinetic drug interaction study on co-administered quetiapine fumarate and divalproex sodium in patients with schizophrenia, schizoaffective disorder, or bipolar disorder.
    Winter HR; DeVane CL; Figueroa C; Ennis DJ; Hamer-Maansson JE; Davis PC; Smith MA
    Hum Psychopharmacol; 2007 Oct; 22(7):469-76. PubMed ID: 17729385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended-release divalproex sodium for patients with side effects from delayed-release divalproex sodium.
    Longo LP
    Am J Psychiatry; 2005 Aug; 162(8):1548-9. PubMed ID: 16055790
    [No Abstract]   [Full Text] [Related]  

  • 11. Tolerability of oral loading of divalproex sodium in the treatment of acute mania.
    Martinez JM; Russell JM; Hirschfeld RM
    Depress Anxiety; 1998; 7(2):83-6. PubMed ID: 9614597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent valproate-induced alopecia in patients with mental disorders.
    Tomita T; Goto H; Yoshida T; Tanaka K; Sumiya K; Kohda Y
    Indian J Pharmacol; 2015; 47(6):690-2. PubMed ID: 26729968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The valproate serum level in maintenance therapy for bipolar disorder in Japan.
    Machino A; Jitsuiki H; Okamoto Y; Izumitani S; Kimura Y; Suzuki K; Tanaka T; Inoue T; Koyama T; Wada K; Masaoka Y; Sasaki T; Yoshimura R; Nakamura J; Sumitan S; Ohmori T; Yamawaki S
    Hiroshima J Med Sci; 2013 Mar; 62(1):7-12. PubMed ID: 23600328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium in Paediatric Patients with Bipolar Disorder: Implications for Selection of Dosage Regimens via Population Pharmacokinetics/Pharmacodynamics.
    Landersdorfer CB; Findling RL; Frazier JA; Kafantaris V; Kirkpatrick CM
    Clin Pharmacokinet; 2017 Jan; 56(1):77-90. PubMed ID: 27393139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of valproic acid in adult Chinese patients with bipolar disorder.
    Zang YN; Guo W; Niu MX; Bao S; Wang Q; Wang Y; Dong F; Li AN; Ruan CJ
    Eur J Clin Pharmacol; 2022 Mar; 78(3):405-418. PubMed ID: 34854947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children.
    Panomvana Na Ayudhya D; Suwanmanee J; Visudtibhan A
    Am J Ther; 2006; 13(3):211-7. PubMed ID: 16772762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapy.
    Gidal BE; Sheth R; Parnell J; Maloney K; Sale M
    Epilepsy Res; 2003 Dec; 57(2-3):85-93. PubMed ID: 15013050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mood stabilizer loading versus titration in acute mania: audit of clinical practice.
    Wheeler A; Robinson G; Fraser A
    Aust N Z J Psychiatry; 2008 Nov; 42(11):955-62. PubMed ID: 18941960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of bipolar affective illnesses with valproate. A review of the literature].
    Retzow A; Emrich HM
    Psychiatr Prax; 1998 Jul; 25(4):163-71. PubMed ID: 9738242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Open randomized comparative twelve-week study of lithium and valproate in manic episode].
    Mosolov SN; Kostiukova EG; Kapiletti SG; Belen'kaia DV; Shafarenko AA; Fedotov DD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(11):47-52. PubMed ID: 20032954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.